Zobrazeno 1 - 10
of 210
pro vyhledávání: '"R J, Hohl"'
Autor:
Cheng, Yan‐Qiong1 (AUTHOR), Zhang, Ruo‐Xi1 (AUTHOR), Li, Xing‐Yuan1 (AUTHOR), Zhou, Xiao‐Ting1 (AUTHOR), Chen, Ming2 (AUTHOR), Liu, Ai‐Jun1 (AUTHOR) mrliuaijun@163.com
Publikováno v:
CNS Neuroscience & Therapeutics. Oct2024, Vol. 30 Issue 10, p1-11. 11p.
Autor:
R J, Hohl
Publikováno v:
Clinical pharmacology and therapeutics. 97(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58873163363e7fd5b852261a69fe8727
https://pubmed.ncbi.nlm.nih.gov/25676878
https://pubmed.ncbi.nlm.nih.gov/25676878
Autor:
J E, Rosenberg, S, Halabi, B L, Sanford, A L, Himelstein, J N, Atkins, R J, Hohl, F, Millard, D F, Bajorin, E J, Small, Nancy, Bartlett
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(5)
There is no standard second-line treatment for advanced urothelial carcinoma (UC). Response rates to second-line chemotherapy for advanced UC are low and response duration is short. Bortezomib is a proteasome inhibitor with preclinical activity again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97afb215baa3f01e4b01ca89e6a43c35
https://pubmed.ncbi.nlm.nih.gov/18272914
https://pubmed.ncbi.nlm.nih.gov/18272914
Autor:
S A, Holstein, R J, Hohl
Publikováno v:
Molecular cancer therapeutics. 1(2)
The hydroxymethylglutaryl-CoA reductase inhibitor lovastatin is used widely to treat hypercholesterolemia and has been shown to have cell cycle-specific effects. In these studies, we have examined the effects of combining lovastatin and paclitaxel (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3468391903f3f50ce1f2c23e56aa167
https://pubmed.ncbi.nlm.nih.gov/12467231
https://pubmed.ncbi.nlm.nih.gov/12467231
Autor:
C P, Burns, S, Halabi, G H, Clamon, V, Hars, B A, Wagner, R J, Hohl, E, Lester, J J, Kirshner, V, Vinciguerra, E, Paskett
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(12)
The purpose of this study was to determine the maximum tolerated dose and dose-limiting toxicities of fish oil fatty acid capsules containing omega-3 fatty acid ethyl esters. Twenty-two patients with neoplastic disease not amenable to curative therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::726e405208c947744e04ba87b4612e87
https://pubmed.ncbi.nlm.nih.gov/10632323
https://pubmed.ncbi.nlm.nih.gov/10632323
Publikováno v:
American journal of hematology. 59(3)
Unexpectedly low hemoglobin oxygen saturation as determined by pulse-oximeter analysis was observed in a patient who underwent an elective surgical procedure. Specific hemoglobin derivatives such as carboxyhemoglobin, methemoglobin, and reduced hemog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::898dda29695ac957f8d24fd280dc35a4
https://pubmed.ncbi.nlm.nih.gov/9798654
https://pubmed.ncbi.nlm.nih.gov/9798654
Autor:
Wang, Qi1,2 (AUTHOR), Li, Lijuan1 (AUTHOR), Gao, Xiaoyan1 (AUTHOR), Zhang, Chunxue1 (AUTHOR), Xu, Chen1 (AUTHOR), Song, Lingyi2 (AUTHOR), Li, Jian2 (AUTHOR), Sun, Xiao1 (AUTHOR) sunxiao@shsmu.edu.cn, Mao, Fei2 (AUTHOR) maofei@mail.ecust.edu.cn, Wang, Yudong1 (AUTHOR) wangyudong@shsmu.edu.cn
Publikováno v:
Advanced Science. 4/17/2024, Vol. 11 Issue 15, p1-15. 15p.
Publikováno v:
Blood. 88(12)
Lovastatin, a cholesterol-lowering drug, has antiproliferative properties that may be related to its inhibition of protein isoprenylation. We examined the effects of lovastatin on signal transduction via the T-cell antigen receptor (TCR). Lovastatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::294711e0f55dcfdb1de671d5f8e0e624
https://pubmed.ncbi.nlm.nih.gov/8977253
https://pubmed.ncbi.nlm.nih.gov/8977253
Publikováno v:
Bone marrow transplantation. 18(3)
Acute decompensating cardiomyopathy induced by cyclophosphamide is usually irreversible. To investigate the clinical course and the outcome of therapy, 13 patients (1.7%) with grade III acute cardiomyopathy and hypotension who were treated with ablat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::149aef9e9ca6e722243a53cf4be09263
https://pubmed.ncbi.nlm.nih.gov/8879620
https://pubmed.ncbi.nlm.nih.gov/8879620
Autor:
A, Thibault, D, Samid, A C, Tompkins, W D, Figg, M R, Cooper, R J, Hohl, J, Trepel, B, Liang, N, Patronas, D J, Venzon, E, Reed, C E, Myers
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 2(3)
Lovastatin, an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (the major regulatory enzyme of the mevalonate pathway of cholesterol synthesis), displays antitumor activity in experimental models. We therefore conducted a Phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24e9f2138ae9addbbc3037900174553c
https://pubmed.ncbi.nlm.nih.gov/9816194
https://pubmed.ncbi.nlm.nih.gov/9816194